Literature DB >> 28379438

Does the fissureless technique decrease the incidence of prolonged air leak after pulmonary lobectomy?

Shuangjiang Li1,2, Wenyu Lv2,3, Kun Zhou1, Guowei Che1.   

Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether the fissureless technique can reduce the incidence of prolonged air leak (PAL) after pulmonary lobectomy. Altogether 18 papers were found using the reported search, of which 1 prospective randomized study and 4 retrospective cohort studies represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Four studies demonstrated that the fissureless technique used in pulmonary lobectomy was superior to conventional lobectomy in terms of preventing PAL and shortening the time to air leak cessation. One study showed no difference in PAL formation between these 2 procedures. The definitions for PAL as defined by duration was >5 days in 4 studies and >7 days in 1 study. Current evidence demonstrates that the fissureless technique can significantly decrease the development of PAL and time to air leak cessation after pulmonary lobectomy.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Fissureless technique; Lobectomy; Prolonged air leak; Review

Mesh:

Year:  2017        PMID: 28379438     DOI: 10.1093/icvts/ivx061

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  Editorial comment on 'Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?'

Authors:  Majed Refai
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Enhanced recovery after surgery and video-assisted thoracic surgery lobectomy: the Italian VATS Group surgical protocol.

Authors:  Alessandro Gonfiotti; Domenico Viggiano; Luca Voltolini; Alessandro Bertani; Luca Bertolaccini; Roberto Crisci; Andrea Droghetti
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

3.  Body surface area is a novel predictor for surgical complications following video-assisted thoracoscopic surgery for lung adenocarcinoma: a retrospective cohort study.

Authors:  Shuangjiang Li; Kun Zhou; Heng Du; Cheng Shen; Yongjiang Li; Guowei Che
Journal:  BMC Surg       Date:  2017-06-12       Impact factor: 2.102

4.  Effects of degree of pulmonary fissure completeness on major in-hospital outcomes after video-assisted thoracoscopic lung cancer lobectomy: a retrospective-cohort study.

Authors:  Shuangjiang Li; Zhiqiang Wang; Kun Zhou; Yan Wang; Yanming Wu; Pengfei Li; Guowei Che
Journal:  Ther Clin Risk Manag       Date:  2018-03-02       Impact factor: 2.423

5.  Prophylactic octreotide does not reduce the incidence of postoperative chylothorax following lobectomy: Results from a retrospective study.

Authors:  Chu Zhang; Hui Zhang; Wenbin Wu; Dong Liu; Dunpeng Yang; Miao Zhang; Cuntao Lu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Presence of pleural adhesions can predict conversion to thoracotomy and postoperative surgical complications in patients undergoing video-assisted thoracoscopic lung cancer lobectomy.

Authors:  Shuang-Jiang Li; Kun Zhou; Yan-Ming Wu; Ming-Ming Wang; Cheng Shen; Zhi-Qiang Wang; Guo-Wei Che; Lun-Xu Liu
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

7.  Multicenter randomized controlled trial comparing digital and traditional chest drain in a VATS pulmonary lobectomy cohort: interim analysis.

Authors:  Paolo Mendogni; Davide Tosi; Giuseppe Marulli; Giovanni Maria Comacchio; Sara Pieropan; Veronica Rossi; Debora Brascia; Luigi Gaetano Andriolo; Giovanna Imbriglio; Gianluca Bonitta; Camillo Lopez; Federico Rea; Mario Nosotti
Journal:  J Cardiothorac Surg       Date:  2021-07-05       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.